© 2021 KOSU
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

As omicron surges, two new drugs approved to treat COVID-19 patients

As cases COVID-19 surge around the country, driven by the omicron variant, there’s some good news too. Two new treatments have been approved by the Food and Drug Administration — both of them pills shown to reduce serious illness, hospitalization and death among high-risk patients.

So what’s the difference between Merck’s Molnupiravir and Pfizer’s Paxlovid? And what other treatments are available as we head into the third year of the pandemic?

Here & Now‘s Celeste Headlee checks in with virologist Angela Rasmussen at the University of Saskatchewan.

This article was originally published on WBUR.org.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Hey! Did you enjoy this story? We can’t do it without you. We are member-supported, so your donation is critical to KOSU's news reporting and music programming. Help support the reporters, DJs and staff of the station you love.

Here's how: